Spain / Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest developments at Spanish firm PharmaMar which hopes its Aplidin can be used as a…
US Biotech Commercialisation Strategies / How Karyopharm & Ionis Are Approaching US vs ROW
With US still the reigning global champion in biotech innovation, the dynamic and vibrant biopharma ecosystem in the world’s largest healthcare market continues to churn out ground-breaking innovations with companies…
Company Spotlight / How Chugai Became Japan's Top Pharma Company
In 2020, Chugai Pharmaceutical Co. became Japan’s biggest drug company, driven by strong performance in recent years both from the company’s own drugs as well as those of parent company…
Rankings / Top 10 Pharma Companies in Saudi Arabia
The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10 corporations account for 50 percent of total sales in…
COVID-19 in Latin America / News Roundup September 2020
The latest from the fight against COVID-19 in Latin America, including J&J’s vaccine trials, issues surrounding Chinese-made diagnostic tests, Colombia’s vaccine manufacturing capacity, and potential compulsory licensing in Brazil. …
Pricing / Italy Takes Global Transparency Lead by Forcing Pharma to Disclose Public R&D Funding
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding public subsidies received for the development of new drugs. The decree…
Middle East & Africa / Pharma News Roundup September 2020
A roundup of the latest news from pharma in the Middle East and Africa including China’s announcement that it will be prioritising Africa for access to its COVID-19 vaccine, UAE…
Norway / 5 Medtechs to Watch
Norway, known more for its expertise in oil and gas and marine biology than in health innovation, is home to increasing numbers of innovative medical technology start-ups. Here are five…
USA / Supporting Value-Based Purchasing Through Changes in Medicaid Best Price
Michael Ciarametaro, VP for Research at the US National Pharmaceutical Council (NPC), outlines issues surrounding the outdated Medicaid Best Price (MBP) and why there is a dire need for payment…
IFPMA / Global Pharma Execs Hail ‘Unprecedented’ Speed & Collaboration of COVID-19 Response
During the fourth International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) COVID-19 media briefing, one thematic dominated: collaboration. With Eli Lilly chairman and CEO David Ricks, also president of IFPMA;…
COVID-19 / Pfizer's Bourla & MSD's Frazier: No Cutting Corners in Vaccine Development & Rollout
Top global pharma executives involved in the development of COVID-19 vaccines have stated their commitment to not rushing the release of any potential vaccine without it passing through the full…
Canada / Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt end to Canada’s participation in CanSino Biologics’ clinical trials the country’s first medical cannabis…